Javier Ruiz-Guiñazú Selected Research

COVID-19 Vaccines

1/2023	Thrombosis with thrombocytopenia syndrome: A database review of clinical trial and post-marketing experience with Ad26.COV2.S.
1/2023	Quantifying Antibody Persistence After a Single Dose of COVID-19 Vaccine Ad26.COV2.S in Humans Using a Mechanistic Modeling and Simulation Approach.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Javier Ruiz-Guiñazú Research Topics

Disease

5	COVID-19 05/2024 - 10/2021
2	Severe Acute Respiratory Syndrome 10/2023 - 01/2023
2	Otitis Media 01/2017 - 01/2017
1	Thrombocytopenia (Thrombopenia) 01/2023
1	Thrombosis (Thrombus) 01/2023
1	Breakthrough Infections 12/2022
1	Rubella (German Measles) 01/2018
1	Poliomyelitis (Polio) 01/2018
1	Measles 01/2018
1	Pneumococcal Infections 01/2018
1	Sudden Infant Death (SID) 01/2017

Drug/Important Bio-Agent (IBA)

8	Ad26COVS1IBA 05/2024 - 10/2021
8	VaccinesIBA 12/2022 - 01/2017
2	COVID-19 VaccinesIBA 01/2023 - 01/2023
2	Conjugate VaccinesIBA 01/2017 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2017
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2018

Therapy/Procedure

1	Injections 12/2022